Science & Nature

Scientists have developed an innovative electronic comb called “Detangle” that could offer a completely new approach to treating androgenetic alopecia, the most common form of hereditary hair loss affecting both men and women. Unlike an ordinary comb, this experimental device uses tiny electrical pulses to deliver therapeutic genetic materials deep into hair follicles, targeting two important processes associated with hair loss. One component is designed to encourage the formation of new blood vessels around hair follicles, improving their blood supply. Another targets an enzyme involved in producing dihydrotestosterone (DHT), a hormone that contributes to the gradual shrinking of susceptible hair follicles. And the results are remarkable! In experiments involving mice with experimentally induced pattern hair loss, the electronic comb restored hair coverage across nearly 100% of the treated area within just 28 days. For comparison, mice treated with conventional topical minoxidil achieved approximately 70% restoration in the same experimental model. The researchers believe that combining electrical stimulation with targeted delivery of therapeutic molecules could make hair-loss treatment more effective by reaching deeper into hair follicles. However, there is an important limitation: these impressive results have so far been demonstrated in mice, not humans. Human clinical trials are still needed to establish whether this technology can safely and effectively treat baldness in people. Nevertheless, the discovery opens an exciting new direction in hair-regrowth research. Original Citation: Feng Liu et al., Combing-triggered electrostimulation synchronizing deep delivery for rapid hair regrowth in androgenetic alopecia, Nature Communications (2026). DOI: 10.1038/s41467-026-79122-3

High blood pressure is usually treated as a lifelong condition requiring endless daily medication, yet roughly one in ten cases is actually driven by a treatable hormonal glitch. In this condition, known as primary aldosteronism, tiny benign cell clusters in the adrenal glands release too much of a hormone called aldosterone, which forces the body to retain salt and water. Until recently, the only permanent cure was surgical removal of the adrenal gland, leaving most patients dependent on daily pills for life. A new study published in the New England Journal of Medicine by researchers at Queen Mary University of London shows that a temporary course of an oral drug called baxdrostat may achieve a lasting cure without surgery. Rather than merely blocking the hormone in the bloodstream, baxdrostat shuts down the exact enzyme the adrenal glands use to manufacture aldosterone. When fourteen patients took the medication for six to twelve months and then stopped completely, both their hormone levels and blood pressure stayed low for up to two years, with nearly a quarter of them needing no blood pressure medication at all. Scientists believe that starving these overactive adrenal cells of their ability to make hormones for several months causes the rogue clusters to shrink and vanish. While this initial study involved a small group of patients, a larger clinical trial called ELIXIR is now underway using advanced medical scans to confirm whether a few months of tablets can permanently replace surgery for millions of people worldwide. Citation: Hyperaldosteronism remission after extended aldosterone synthase inhibition, New England Journal of Medicine (2026). DOI: 10.1056/NEJMc2611265

Emergency public health spending is often viewed as a heavy financial burden, yet new data reveals that rapid vaccine innovation is one of the highest-yielding investments in human history. A global study published in PLOS Medicine by researchers from the London School of Hygiene and Tropical Medicine, Imperial College London, and New York University evaluated the exact financial and health return of the COVID-19 vaccination rollout across 173 countries during its first year, from December 2020 to December 2021. ​The research team found that the world spent approximately 79.4 billion dollars on research, manufacturing, advance purchasing, and delivery for the initial wave of vaccines. In return, that twelve-month immunization effort prevented 1.5 billion infections and 51.5 million hospitalizations worldwide. When accounting for saved lives, preserved work productivity, and 221 billion dollars in avoided hospital care, the rollout generated between 6.43 trillion and 64.3 trillion dollars in global value. Put simply, every single dollar invested in COVID-19 vaccines returned between 60 and 809 dollars in economic and health benefits. ​While wealthier nations captured the highest overall monetary returns due to earlier vaccine access, lower-income countries experienced the greatest relief in avoided medical expenses and protected workforces relative to the size of their local economies. Led by researchers Hallie Benjamin, Gregory Barnsley, Oliver J. Watson, and Mark Jit, the analysis proves that funding rapid vaccine science and ensuring fair global distribution is both a life-saving necessity and an extraordinary economic safeguard against future pandemics. Paper details: Benjamin H, Barnsley G, Watson OJ, Jit M (2026) Global return-on-investment of COVID-19 vaccines in the first year of the vaccination programme: A model-based economic evaluation. PLOS Medicine 23(11): e1004772. DOI: 10.1371/journal.pmed.1004772

Every living thing on Earth relies on the exact same five-letter chemical alphabet (adenine, guanine, cytosine, thymine, and uracil)to build DNA and RNA. A landmark study published in Nature Astronomy by Toshiki Koga, Yasuhiro Oba, Yoshinori Takano, and their colleagues has now confirmed that all five of these essential genetic building blocks exist together inside a single pristine space rock: the ancient asteroid Ryugu. Unlike meteorites that crash into Earth and risk getting contaminated by terrestrial microbes, Ryugu's dark pebbles were collected directly in deep space by Japan's Hayabusa2 spacecraft and sealed in airtight capsules. By analyzing intact rock fragments with ultra-sensitive equipment, the team unlocked the complete five-part genetic toolkit along with non-biological twin molecules, proving these compounds were forged through lifeless cosmic chemistry rather than alien biology. Even more intriguing, while other space rocks like the asteroid Bennu show heavily lopsided mixtures of these bases, Ryugu holds a nearly perfect balance of the two main chemical families -- a puzzle tied to the specific blend of liquid water and ammonia that once flowed inside the asteroid billions of years ago. This discovery reveals that our solar system was naturally manufacturing the complete chemical alphabet of life inside freezing interstellar clouds and dark asteroids before Earth even finished forming. As rocks like Ryugu bombarded the young Earth, they seeded our primordial oceans with ready-made genetic ingredients, shifting the ultimate mystery from where the building blocks of life came from to how our planet first sparked them into a living cell. Source article: Koga, T., Oba, Y., Takano, Y. et al. A complete set of canonical nucleobases in the carbonaceous asteroid (162173) Ryugu. Nat Astron 10, 655–663 (2026). DOI: 10.1038/s41550-026-02791-z

Heart disease was long considered a condition where medication could only slow down future artery blockages rather than undo existing damage. A clinical trial published in JAMA Cardiology now shows that aggressive cholesterol-lowering treatment can actively reverse plaque buildup across the heart's entire blood vessel network. Researchers led by Martin Bødtker Mortensen tracked 104 newly diagnosed heart patients over 18 months using detailed 3D heart scans. Patients who took a powerful two-drug combination of rosuvastatin and ezetimibe slashed their bad cholesterol by 65 percent, shrinking their total artery plaque by more than 21 percent. Most impressively, the soft, fatty deposits - the unstable kind most likely to rupture and cause a sudden heart attack - dropped by 28 percent. Nearly every patient on the dual therapy saw this dangerous soft plaque retreat, leaving the remaining artery walls firmer and much more stable. Starting early with a strong combination of standard, widely available medications does far more than just protect the heart from future harm. It actively clears out vulnerable fatty buildup and helps restore healthier arteries without relying solely on invasive procedures. Paper reference: Martin Bødtker Mortensen et al., Intensive vs More Intensive Lipid-Lowering Therapy and Plaque Regression in Statin-Naive Patients, JAMA Cardiology (2026). DOI: 10.1001/jamacardio.2026.4788

Replacing ordinary table salt with potassium-enriched salt could prevent nearly three million deaths worldwide every year. A new global study published in the journal Nature Health highlights how this simple swap in the kitchen across 193 countries could dramatically reduce rates of heart and kidney disease. High blood pressure affects 1.4 billion adults globally and is fueled by modern diets that contain too much sodium and too little potassium. Potassium-enriched salt solves both issues at once by replacing a portion of regular sodium chloride with potassium chloride, a safe mineral alternative that looks, tastes, and cooks just like normal salt. Researchers at The George Institute for Global Health found that a complete worldwide switch in both home cooking and commercial food production would prevent 2.96 million deaths and over 10 million cases of cardiovascular and kidney disease annually. Even switching household cooking salt alone would save 1.85 million lives a year, including nearly 400,000 lives annually in India. While people with advanced kidney disease must be cautious with potassium intake, the study confirmed that the life-saving drop in blood pressure outweighs potential risks by more than seven to one, making potassium-enriched salt one of the simplest and most effective public health tools available today. Paper details: Huang, L., Xu, X., Matsushita, K. et al. Global health outcomes from replacing dietary sodium chloride with potassium-enriched salt. Nature Health (2026). DOI: 10.1038/s44360-026-00216-9

Roughly 240 million teenagers around the world go through an entire week without a single day of proper physical exercise. Analyzing data from 3.2 million students aged 11 to 17 across 140 countries, researchers from the World Health Organization and the University of Edinburgh found that 86 percent of adolescents fail to get the recommended 60 minutes of daily physical activity. Even more concerning, a full 25 percent of teenagers globally report zero active days in a typical week, depriving their growing bodies of movement essential for strong bones, heart health, and mental well-being. This inactivity crisis hits teenage girls the hardest across every region of the world. Globally, 28 percent of girls experience zero active days per week compared to 22 percent of boys, driven by safety concerns, cultural barriers, and fewer opportunities to join community sports. Because global activity levels have barely shifted since 2010, not a single country is on track to meet the 2030 global target of reducing physical inactivity by 15 percent. Reversing this trend requires much more than simply advising teenagers to spend less time on their screens. The researchers emphasize that schools and communities must build environments that make daily movement effortless, from safe walking and cycling routes to inclusive sports programs designed to get young people (especially girls) moving again. Citation: Strain T, Flaxman S, Ricardo L et al. National, regional, and global trends in adolescent physical activity from 2010 to 2025: a pooled analysis of 389 surveys with 3·2 million participants from 140 countries, The Lancet Global Health, 2026; DOI: 10.1016/j.langlo.2026.104099

Conventional cancer treatments like chemotherapy and radiation destroy rapidly dividing cells, a forceful approach that inevitably harms healthy tissue alongside the tumor. Researchers at the Korea Advanced Institute of Science and Technology (KAIST), led by Professor Kwang-Hyun Cho, have now demonstrated a gentler alternative that reprograms colorectal cancer cells back into normal-like intestinal cells without killing them. Published in Advanced Science, the team developed a computer modeling tool called BENEIN to map the complex genetic circuits that guide young intestinal cells into healthy maturity. In cancer, this circuit gets stuck, locking cells into endless division. By building a digital twin of the gene network, the researchers identified three master switches (MYB, HDAC2, and FOXA2) that act together to trap colorectal cells in a malignant state. When the scientists simultaneously switched off all three genes in human cancer cells and mouse tumors, the malignancy reversed. The cells shut down their aggressive growth signals, shrank in tumor size, and reactivated the genetic behavior of healthy intestinal tissue. By targeting the exact switches that control cell identity rather than using toxic chemicals to kill cells outright, this breakthrough opens the door to future cancer therapies with minimal side effects. Research paper: Gong, J.-R., Lee, C.-K., Kim, H.-M., Kim, J., Jeon, J., Park, S., & Cho, K.-H. (2025). Control of Cellular Differentiation Trajectories for Cancer Reversion. Advanced Science, 12, 2402132. DOI: 10.1002/advs.202402132

Shifting your bedtime to an earlier hour may be an unexpected secret to shedding extra weight, even if the total number of hours you sleep stays the same. Most health advice for managing weight and preventing type 2 diabetes focuses on eating well, exercising regularly, and getting enough hours of rest. However, new clinical research shows that the actual time of night you fall asleep plays its own distinct role in how the body manages weight. A research team led by Susan Kohl Malone recently explored this link in an eight-week clinical trial published in the journal Nursing Research. The study followed 196 adults living with prediabetes who routinely got too little sleep. All participants received one-on-one video coaching focused on healthier eating and daily physical activity, while half of the group also received specialized sleep coaching designed to gradually move their bedtimes earlier by 15 minutes each week. Using wearable wrist sensors to monitor sleep schedules and continuous glucose monitors to track blood sugar, the researchers measured how these changes affected overall metabolic health. At the end of the eight weeks, adding sleep coaching did not create a bigger drop in daily blood sugar levels compared to diet and exercise alone, as both groups slept slightly longer and lost a modest amount of weight. Yet the group trained in sleep habits experienced much better sleep quality and felt far more alert during the day. Even more fascinating was a pattern that emerged across the entire study population: regardless of which group they were in or how many total hours they slept, participants who started falling asleep earlier at night lost significantly more weight than those who stayed up late. This discovery points to our internal biological clock as an overlooked factor in everyday weight management. Falling asleep earlier helps align our rest with natural circadian rhythms, which can curb late-night snacking and keep appetite hormones in check in ways that simply sleeping in later cannot replicate. For anyone working to improve their metabolic health, pairing a balanced diet and regular movement with a bedtime that starts just 15 to 30 minutes earlier could make weight loss much more achievable. Article citation: Susan Kohl Malone et al., Randomized Controlled Trial of Lifestyle Plus Sleep Extension Intervention on Adults With Prediabetes and Short Sleep, Nursing Research (2026). DOI: 10.1097/nnr.0000000000000957

People who survive a brush with death often return with vivid memories of otherworldly environments, yet they almost always struggle to describe what they saw using everyday words. To overcome the limits of spoken language, an international team of researchers asked 50 people who experienced a near-death event to sit down and sketch the exact geometry of the spaces they entered. Published in the journal Frontiers in Psychology by France Lerner, Paulo Cezar Rocha dos Santos, and Guillaume Tahar, this landmark study mapped 108 distinct visual scenes and uncovered a hidden architectural blueprint inside the human mind. As the researchers measured the angles and boundaries of every drawing, they noticed that four specific shapes kept showing up across completely independent accounts. Survivors consistently sketched narrow tunnels, wide archways, gently curved spaces, and immersive, sphere-like bubbles that wrapped completely around their point of view. Even when separated by personal background and culture, the participants' brains constructed their near-death environments using these exact same geometric structures, moving from tight pathways into vast, panoramic enclosures. The strangest finding emerged when the scientists compared the shape of each space to the colors people perceived inside them. Tunnels were almost always colorless, with 22 out of 28 tunnel scenes experienced entirely in stark shades of black, white, and gray light. In dramatic contrast, the wide archways were almost always full of vibrant color, appearing in 27 out of 31 scenes. Gently curved spaces and full spherical bubbles also frequently featured rich, luminous hues, showing that color perception in these states is tightly bound to the geometry of the visual field. This striking pattern reveals that near-death visions are far from random or chaotic hallucinations. Instead, they follow strict rules tied to how our visual system is wired. When the brain faces a severe physiological crisis, basic visual processing creates narrow, colorless tunnel vision focused purely on light and dark contrast. As the internal experience expands into wide archways and 360-degree spheres, deeper neural networks responsible for spatial awareness and full-spectrum color appear to come online, shaping one of humanity's most profound perceptual mysteries. Publication details: Lerner F, dos Santos PCR and Tahar G (2026) The perceptual geometry and chromaticity of near-death experience spaces. Front. Psychol. 17:1760389. DOI: 10.3389/fpsyg.2026.1760389

Scientists at the University of Bonn, University Hospital Bonn, and RWTH Aachen University have discovered how to convert elderly human blood cells directly into brain stem cells while stripping away more than 60 years of biological aging. Published in the journal Aging Cell by Lea Jessica Berg, Oliver Brüstle, and their colleagues, the study shows that blood cells from donors up to 101 years old can have their internal aging clocks rewound to match those of someone under 20. As we age, our DNA accumulates chemical tags that track cellular wear and tear. Previously, erasing these marks required forcing adult cells all the way back into an embryonic blank slate, which wiped away cellular age too quickly for scientists to observe how the reset actually worked. By introducing just two genetic switches directly into immature red blood cells, the German team bypassed that embryonic stage altogether, guiding the blood cells to transform directly into self-renewing neural stem cells. During this transformation, the cells rejuvenated in slow motion over more than 100 days, with cells from an 80-year-old donor shedding over six decades of molecular age within the first 50 days. The researchers also proved that this age reversal happens even when cell division is paused, confirming that the cells actively clean up their own DNA rather than simply diluting old markers as they multiply. This slow-motion window into cellular rejuvenation could ultimately help scientists design new therapies to repair aging brain tissue and combat neurodegenerative diseases like Alzheimer's and Parkinson's. Research Paper: Berg, L. J., Franzen, J., Buness, A., et al. (2026). Protracted Fate Acquisition and Epigenetic De-Aging During Induced Neural Stem Cell Conversion of Human Blood Cells. Aging Cell, 25(10), e70751. DOI: 10.1111/acel.70751

Millions of people with major depression get little relief from daily medications, leaving them battling a stubborn condition known as treatment-resistant depression. A new clinical trial published in the journal JAMA reveals that a single dose of a fast-acting psychedelic nasal spray can deliver rapid and lasting recovery. Unlike conventional pills that take weeks to take effect, one spray into a single nostril eased severe depressive symptoms within two days, with mood improvements holding steady for up to eight weeks. The spray delivers synthetic mebufotenin, a psychedelic compound found naturally in certain plants and the Sonoran Desert toad. While other psychedelics like psilocybin and LSD require patients to remain under medical supervision for up to twelve hours, mebufotenin stimulates mood-regulating serotonin receptors on a fraction of that timeline, peaking in minutes and wearing off in under an hour. Across 193 patients treated at 38 medical centers, those given an active 8 or 12 milligram dose alongside psychological support experienced substantial drops in depression severity compared to the control group. Side effects were mostly mild and brief, allowing roughly 80 percent of treated patients to be medically cleared to go home within two hours. By shrinking a full-day psychedelic therapy session into a routine two-hour outpatient visit, this single-dose nasal spray could remove a major logistical bottleneck in psychiatry and bring rapid relief to everyday medical clinics. Article source: Feifel D, Seynaeve M, Cubała WJ, et al. Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA. Published online October 26, 2026. DOI: 10.1001/jama.2026.18380

Lawmakers in Tennessee recently introduced Senate Bill 1949, joining similar proposals in Minnesota and Arizona that sought to classify mRNA vaccines as biological weapons of mass destruction. While the legislation generated intense debate online, it failed to advance and died in committee without a vote. These proposals rely on the mistaken idea that messenger RNA permanently alters human DNA and replicates endlessly in the body. In reality, mRNA is just a temporary biological recipe. It stays in the outer fluid of the cell to help build a harmless protein that trains our immune system, never entering the cell nucleus where our DNA is stored. The chemical tweak cited in the bill as sinister actually won the 2023 Nobel Prize in Medicine for helping the fragile instructions survive just long enough to be read before natural enzymes break them down completely within a few days. Medical experts also warned that banning this technology would block vital breakthroughs beyond infectious diseases. Researchers are currently using the exact same mRNA platform to build personalized cancer vaccines and treatments for rare genetic disorders, proving why basic biology must guide healthcare policy over fear. Article Sources: Tennessee General Assembly (Senate Bill 1949, 114th General Assembly); The Nobel Assembly at Karolinska Institutet (2023 Prize in Physiology or Medicine); Immunity (DOI: 10.1016/j.immuni.2005.06.008).

Medical science has just crossed a historic milestone. Results from the landmark Phase 3 INTerpath-001 clinical trial confirm that a custom-made mRNA cancer therapy, developed by Moderna and Merck, significantly keeps deadly skin cancer from returning after surgery. This is the first time a personalized mRNA cancer vaccine has ever succeeded in a late-stage Phase 3 study. Designed for patients who have had high-risk melanoma surgically removed, the therapy targets the microscopic cancer cells that often stay hidden in the body and cause relapses. Doctors sequence the DNA of a patient’s removed tumor to map its unique genetic mutations, then build a tailored mRNA dose containing up to 34 distinct markers from that specific tumor. Once injected, it trains the patient’s immune system to recognize those exact markers and hunt down any lingering cancer cells. In a global trial of 1,137 patients, combining this custom vaccine with the standard immunotherapy drug Keytruda cut the risk of cancer recurrence or death by 42%, and reduced the risk of distant cancer spread by 38%, compared to Keytruda alone. Even more remarkably, once the full vaccination course took effect after the first six months, the risk of relapse or death dropped by 58%. Adding the personalized vaccine did not increase severe immune side effects, causing mostly mild and temporary reactions like fatigue, fever, and arm soreness. With regulatory filings now underway for melanoma and trials expanding into lung, bladder, and kidney cancers, tailored mRNA therapies are set to transform how we keep cancer in remission. Sources: Phase 3 INTerpath-001 Trial (NCT05933577), ESMO Congress 2026 / Merck & Moderna Clinical Release. American Association for Cancer Research, Personalized Melanoma mRNA Vaccine Delivers Phase III Success (October 26, 2026):

Sleeping in a parked car or resting in a public park is rapidly shifting from a sign of economic hardship to a criminal offense across the United States. This reality came into sharp focus in Nashville, Tennessee, when a forty-nine-year-old unhoused man named Joseph Lamont Williams was arrested at the park where he had lived for years. Under Tennessee law, which uniquely classifies public camping as a felony, Williams initially faced up to six years in state prison simply for having nowhere else to sleep. Although prosecutors eventually dropped the felony counts after he spent nine days in jail, Williams was still handed nearly four hundred dollars in court fees for a lesser misdemeanor charge. With no money and nowhere to go, he returned to the exact same park the day he was released. His ordeal reflects a sweeping national crackdown following a 2024 Supreme Court ruling that allowed cities to punish people for sleeping outside even when local shelters are completely full. Since then, over three hundred cities have passed or tightened bans on sleeping in public spaces and vehicles. While supporters argue that strict enforcement keeps public areas safe, social researchers warn that we cannot arrest our way out of a housing crisis. Saddling someone who cannot afford rent with court fines and a criminal record only makes it harder for them to pass background checks for a job or an apartment. Ultimately, treating homelessness as a crime rather than an economic challenge does not solve the problem; it merely traps vulnerable people in a costly cycle between jail cells and city streets. Source: Marissa J. Lang, NPR, July 21, 2026, “A homeless man was charged with a felony for camping. He's one of the first.”

Alzheimer's disease and heart disease share a surprising connection inside the aging liver. A new study led by researchers at the University of Southern California reveals that rejuvenating a single population of aging liver cells can restore the body's natural ability to clear out both Alzheimer's-linked proteins and harmful cholesterol. In a young, healthy body, the liver continuously cleans the blood by filtering out amyloid-beta, the sticky protein that forms brain plaques in Alzheimer's, along with artery-clogging LDL cholesterol. Blood first passes through a specialized lining of liver cells that act like a microscopic sieve, which also releases a chemical signal telling the main liver cells to put out molecular hooks and capture this passing waste. As the body ages, the tiny pores in these lining cells close up, and they lose the ability to send out their vital chemical signal, causing both harmful substances to build up in the bloodstream. When scientists treated aged rats for two weeks with an experimental drug called cinaciguat, the aging lining cells reopened their pores and resumed sending their chemical instructions. In response, the main liver cells restored their surface hooks, cutting blood levels of amyloid-beta in half and returning LDL cholesterol to youthful levels. While these results come from animal studies, they point toward a promising new strategy to protect both the brain and the heart by reviving the liver's natural filtration system. Citation: Sam J. de Leve et al., Reversing liver sinusoidal endothelial aging restores clearance of amyloid-beta and LDL, Journal of Biological Chemistry (2026). DOI: 10.1016/j.jbc.2026.113608

Pancreatic cancer is notoriously difficult to treat because its cells can constantly adapt, spread rapidly, and outsmart therapy. A new study published in Nature Genetics by researchers at NYU Langone Health and UC San Diego Health has uncovered how these tumors rewrite their own DNA to survive, while revealing a potential way to reverse their deadliest behavior. By analyzing nearly half a million individual cells from 62 human tumors, scientists discovered that a pancreatic tumor is not a uniform mass. Instead, it is an evolving ecosystem containing up to 11 distinct sub-families of cancer cells living side by side. As these cell groups alter their genetic code over time, some develop resistance to chemotherapy while others gain the ability to spread to surrounding tissues. The team pinpointed a specific gene called MYC as the main switch behind this dangerous evolution. When cancer cells acquire extra copies of the MYC gene, they shift from a slower-growing form into a highly aggressive state and simultaneously cloak themselves from the body's immune system. Crucially, this transformation is not permanent. When researchers blocked the MYC gene in laboratory models, the aggressive cancer cells reverted to their slower, more manageable state and became visible to immune cells again. The team also found that these tumors rely on a protein called TIGIT to evade immune detection, explaining why standard immunotherapies often fail against pancreatic cancer and pointing toward promising new combination treatments. Paper details: Kalfakakou, D., Cameron, D.C., Kawaler, E.A. et al. Clonal heterogeneity in human pancreatic ductal adenocarcinoma and its impact on tumor progression. Nature Genetics (2026). DOI: 10.1038/s41588-026-02779-5

Chemotherapy is designed to destroy rapidly dividing cancer cells, yet many tumors survive treatment by slipping into a dormant, zombie-like state known as senescence. Although these zombie cells permanently stop dividing, they refuse to die. Instead, they linger inside the body and release chemical signals that mimic a wound, tricking the immune system into nourishing the surviving tumor so it can recover and cause a relapse. Researchers at Trinity College Dublin, led by Dr. Gokhan Gunay and Professor Seamus Martin, have discovered how cancer cells pull off this escape act and uncovered a hidden weakness to destroy them. When chemotherapy attacks a tumor, it flips built-in self-destruct switches on the cells called death receptors. To survive, cancer cells deploy protective shield proteins known as IAPs to block these switches at the last second, diverting themselves into the dormant zombie state. Crucially, because the self-destruct switches remain active beneath the surface, the zombie cells become completely addicted to this protein shield just to stay alive. When the researchers treated chemotherapy-exposed cancer cells with targeted drugs that strip away these protective proteins, the waiting self-destruct machinery immediately took over and wiped the zombie cells out. Pairing standard chemotherapy with shield-blocking medications could soon provide a powerful one-two punch in cancer care, clearing out the stubborn survivor cells that drive relapse and significantly improving patient outcomes. Source: Gokhan Gunay et al., Death receptors regulate entry to therapy-induced senescence and orchestrate addiction to IAPs, Science Advances (2026). DOI: 10.1126/sciadv.aed4541.

According to the laws of physics, the Big Bang should have created equal amounts of matter and antimatter, which would have instantly destroyed each other on contact and left behind an empty universe. To help figure out why matter survived to form stars, planets, and life, physicists at Northwestern University have achieved a major milestone by trapping a single particle of antimatter for months at a time and controlling its behavior at the quantum level. Studying antimatter is famously difficult because it vanishes in a flash of energy the moment it touches an ordinary container wall. In a new study published in Physical Review Letters, doctoral researcher Thomas G. Myers and Professor Gerald Gabrielse bypassed this hurdle by building an invisible cage of magnetic and electric fields to suspend a single positron, the antimatter twin of the everyday electron - safely in midair. By chilling the chamber to less than a third of a degree above absolute zero, the team froze out stray gas molecules so the particle could survive for months, while draining its energy until it settled into its quietest possible quantum state. Once the positron was sitting completely still, the scientists used precisely tuned microwaves to gently nudge the particle between tiny energy steps and flip its internal magnetic orientation, reading out its behavior repeatedly without destroying it. This unprecedented control allows physicists to measure the magnetic strength of a positron and compare it directly against an ordinary electron with more than thirty times greater precision than ever before. Current theories insist that matter and antimatter must obey the exact same physical rules. If this head-to-head comparison reveals even the slightest mismatch between the electron and its antimatter twin, it will expose a long-sought crack in the laws of nature and offer a vital clue to how our universe came to exist. Journal Reference: T. G. Myers et al., "One-Positron Quantum Cyclotron," Physical Review Letters 137, 173001 (2026). DOI: 10.1103/gbkc-6nlj

Aggressive lung cancers often resist standard treatments because of a genetic flaw where tumor cells duplicate a specific segment of their own DNA, known as chromosome 3q. While scientists have long recognized that this extra DNA fuels rapid tumor growth and spread, finding a way to target and shut down the genes inside this region has remained a major hurdle in cancer research. A new study published in the Proceedings of the National Academy of Sciences by researchers at UTHealth Houston has uncovered the hidden mechanism behind these stubborn tumors. Led by Dr. Xiaochao Tan, the team found that the duplicated DNA causes cancer cells to mass-produce an enzyme called phospholipase D1. This enzyme hijacks the cell's internal post office, the Golgi apparatus, forcing it into overdrive so the tumor can continuously pump out growth-promoting signals into the surrounding tissue. While this hyperactive shipping system helps the cancer thrive and spread, it also creates a fatal weakness because the tumor becomes completely addicted to it. To exploit this dependency, the researchers designed a targeted therapy that acts like a biological guided missile, locking onto a surface protein abundant on these lung cancer cells to deliver an enzyme-blocking drug directly inside the tumor. In preclinical models, this precise strike shut down the rogue shipping process and halted tumor growth, offering a promising new strategy for treating some of the most difficult lung cancers. Citation details: Xiaochao Tan et al., PLD1-driven oncogenic secretion creates a therapeutic vulnerability in chromosome 3q–amplified NSCLC, Proceedings of the National Academy of Sciences (2026). DOI: 10.1073/pnas.2532484123